MoneyWorks4Me

Syncom Healthcare submits statement on investor complaints

15 Apr 2017 Evaluate

Pursuant to the provision of Regulation 13(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulation, 2015, Syncom Healthcare has submitted a Statement on Investor Complaints for the quarter ended 31st March 2017.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..